Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rafael Holdings
AddedFeb 19, 2024
UpdatedJun 28, 2026
Rafael Holdings

Rafael Holdings

Public

Rafael Holdings, Inc.: A US-based holding company specializing in real estate development and cancer therapeutics.

HQ
Newark, NJ, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Rafael Holdings, Inc., founded as a US-based holding company, specializes in real estate development and cancer therapeutics. The company's core mission is to develop novel cancer and immune therapies that address high unmet medical needs. Rafael Holdings is a significant investor in two clinical-stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. The company also seeks opportunities to invest in, acquire, or in-license additional therapeutic assets.

Notable affiliated people include the leadership teams of Cornerstone Pharmaceuticals and LipoMedix Pharmaceuticals, who are key to advancing the company's oncology initiatives. Rafael Holdings' key achievements include substantial investments in promising cancer therapeutics that have the potential to improve and extend patients' lives. The overall impact of Rafael Holdings lies in its dual focus on real estate and innovative cancer treatments, aiming to make significant contributions to both fields.

Rafael Holdings - Similar Companies

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

Oncoholdings logo

Oncoholdings

Bio-Path Holdings logo

Bio-Path Holdings

L.E.A.F. Pharmaceuticals logo

L.E.A.F. Pharmaceuticals

Raze Therapeutics logo

Raze Therapeutics

razetx.com

Kestrel Therapeutics logo

Kestrel Therapeutics

Halda Therapeutics logo

Halda Therapeutics

haldatx.com

Rapt Therapeutics logo

Rapt Therapeutics

rapt.com

Oncofactor logo

Oncofactor

oncofactor.com

Verastem logo

Verastem

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Concarlo Holdings logo

Concarlo Holdings

concarlo.com

Stellanova Therapeutics logo

Stellanova Therapeutics

stellanovatx.com

Reven Holdings logo

Reven Holdings

reven.com

Rainier Therapeutics logo

Rainier Therapeutics

Rafael Holdings - Quick Facts

Who are Rafael Holdings' competitors?

Companies similar to Rafael Holdings include Checkpoint Therapeutics, Oncoholdings, Bio-Path Holdings and L.E.A.F. Pharmaceuticals.

When was Rafael Holdings founded?

Rafael Holdings was founded in 2017.

Where is Rafael Holdings' headquarters located?

Rafael Holdings' headquarters is located in Newark, NJ, US.

When was Rafael Holdings' last funding round?

Rafael Holdings' most recent funding round was for $104.2M (USD) in August 2021.

How much has Rafael Holdings raised to-date?

As of Aug 20, 2021, Rafael Holdings has raised a total of $104.2M (USD).

How many employees does Rafael Holdings have?

Rafael Holdings has 13 employees as of Feb 6, 2024.

Rafael Holdings - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Investment
Customer
  • Enterprise
Main Product
  • Cancer Therapeutics
  • Real Estate
Tags
  • Healthtech
  • Holding
Unique IDs
  • ein: 822296593
  • secCik: 0001713863
  • ticker: RFL
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 6500Real Estate
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research